Accordingly, the selective activation of the neuropeptide Y receptor by PYY (3–36) suppresses appetite, reduces acute food intake, causes body weight loss and provides a promising approach to obesity management. Here, PYY is linked to obesity due to melanocortin 4 receptor deficiency.